Talent: Developing Our Competitive Advantage
by Mara Aspinall, Health Catalysts Panelists: Stacie
Mallen, Vice President of Human Resources at Ulthera, Inc.; Brady
Young, VP of HR for TGen, Adrienne Scheck, PhD, Associate Professor of
Neurobiology at Barrow
Neurological Institute; Tom Longstreth, Ventana Medical Systems, Inc., a
member of the Roche Group
Closing Keynote - Dr. Glen Weiss of Cancer Treatment Centers of America
Glen Weiss, MD, MBA
Director of Clinical Research & Medical Oncologist
Western Regional Medical Center
Cancer Treatment Centers of America
The clinical research and trials program at Cancer Treatment Centers of America in Goodyear, Arizona has exponentially grown under the leadership of Dr. Glen Weiss. Join us to learn more about groundbreaking new trials taking place here in our state - trials utilizing chemotherapy and immunotherapy together to harness the body's own immune system. Also, hear about CTCA’s vision for the future of cancer care.
2019 AZBio Pioneer Award for Lifetime Achievement - Governor Jane Dee Hull
AZBio Pioneer Award for Lifetime Achievement is the highest honor awarded
by Arizona’s bioscience community and is extended to an Arizonan whose
body of work has made life better for people at home and around the world.
In 2019, we honor The Honorable Jane Dee Hull for the lasting impact her
leadership has made on our bioscience industry and the State of Arizona.
Looking back over close to six decades, there are many words that describe
this incredible woman: wife,
mother, grandmother, teacher, legislator, first woman elected Speaker of
the Arizona House of
Representatives, Arizona Secretary of State, 20th Governor of the
State of Arizona beginning in 1997,
first woman elected Governor of Arizona in 1998, and public
delegate from the United States to the United Nations General
Assembly in 2003.
2019 Arizona Bioscience Company of the Year - Regenesis Biomedical
is real. If it is your pain, relief can be life changing. Regenesis
Biomedical discovered an underutilized therapy and developed a unique
platform that is delivering a solution to help patients manage their pain
with a safe, easy to use, non-drug medical device.
Regenesis offers the Provant® Therapy System, an FDA-cleared medical device that is a safe, prescriptive non-drug alternative to opioids. Regenesis’ customers include health care facilities and providers that serve patients treated in hospitals, rehabilitation centers, outpatient clinics, and by patients self-treating at home.
2019 Jon W. McGarity Bioscience Leader of the Year - Dr. Martha Brumfield
probably know someone who is waiting for a cure. Most of us do. It can take over 15 years and a billion
dollars or more to bring a new life-saving or life-changing treatment to
the people who are waiting for it,.
Throughout her career, Dr. Brumfield has worked to bring new, safe,
and effective treatments to market for patients who are waiting.
Research is Everything – Mara Aspinall, BlueStone Venture Partners (2019)
Aspinall, Managing Director of BlueStone Venture Partners, shares insights on
the vital role of research in the development and delivery of life changing and
life saving innovations at the 2019 AZBio Awards
2017 Arizona Bioscience Researcher of the Year Laurence Hurley, PhD
Laurence Hurley, PhD, is the Howard Schaeffer Chair in Pharmaceutical Sciences at the University of Arizona College of Pharmacy and director of the UA BIO5 College of Pharmacy Drug Discovery and Development Program. He also is a research member of the UA Cancer Center, among other roles. He is the leading authority on the identification of small molecule therapeutic agents that target DNA quadruplexes, which are unique four-stranded DNA structures that control gene expression.
2019 Arizona Bioscience Researcher of the Year - Dr.Monica Kraft
than 25 million Americans have asthma. This includes 7.7 percent of adults
and 8.4 percent of children according to 2018 data from the U.S. Centers
for Disease Control and Prevention. Dr. Kraft is an internationally
renowned physician-scientist who specializes in translational asthma
research. She focuses her work on precision medicine therapies to treat
severe asthma. Her research has been funded by the National Institutes of
Health (NIH) and the American Lung Association for nearly 25 years. As a
principal investigator, she currently is in the third year of a 5-year,
$7.02 million grant from the National Institute of Allergy and Infectious
Diseases, an NIH unit, to study “Dysfunction of Innate Immunity in
Asthma,” and in the first year of a 6-year, $2.42 million grant from the
National Heart, Lung, and Blood Institute, another NIH unit, for
participation in the PrecISE Network, a national research network that
evaluates precision medicine approaches for the treatment of severe
asthma. She also is principal investigator on an Arizona Biomedical
Research Commission grant and co-principal investigator with Lynn Gerald,
PhD, MSPH, as the UA is a site for the American Lung Association Clinical
Research Centers to evaluate new treatments for asthma and chronic
obstructive pulmonary disease (COPD).
2019 Michael A. Cusanovich Bioscience Educator of the Year - Dr. Marti Lindsey
opportunities are all around us. Many of these opportunities are thanks to
dedicated educators who work to make them engaging, enlightening and
memorable. They help us understand the world we live in today and provide
tools we can use to shape our tomorrows. Dr. Marti Lindsey is a great
example of an educator who is making a difference here in Arizona and
across the Southwest region.